Ascentage Pharma Group Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Ascentage Pharma Group Corporation's estimated annual revenue is currently $31.2M per year.
- Ascentage Pharma Group Corporation's estimated revenue per employee is $201,000
Employee Data
- Ascentage Pharma Group Corporation has 155 Employees.
- Ascentage Pharma Group Corporation grew their employee count by 6% last year.
Ascentage Pharma Group Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.2M | 36 | 3% | N/A | N/A |
#2 | $7.6M | 38 | 6% | N/A | N/A |
#3 | $11.5M | 57 | 2% | N/A | N/A |
#4 | $315.4M | 1569 | 18% | N/A | N/A |
#5 | $25.9M | 129 | 5% | N/A | N/A |
#6 | $98.1M | 488 | 15% | N/A | N/A |
#7 | $12.9M | 64 | 28% | N/A | N/A |
#8 | $31.2M | 155 | 6% | N/A | N/A |
#9 | $27.3M | 136 | 42% | N/A | N/A |
#10 | $7.8M | 39 | 26% | N/A | N/A |
What Is Ascentage Pharma Group Corporation?
Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Based on breakthrough technology from the University of Michigan, the Company's expertise is in designing therapeutics that inhibit protein-protein interactions to restore apoptosis, or programmed cell death, in cancers. Ascentage has built a rich pipeline of six clinical candidates, including a novel, highly potent Bcl-2/Bcl-xL inhibitor, APG-1252, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors. For more information, please visit www.ascentagepharma.com.
keywords:N/A
N/A
Total Funding
155
Number of Employees
$31.2M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ascentage Pharma Group Corporation News
In March 2022, Luye Pharma Group announced that it has filed a New ... In March 2022, Harpoon Therapeutics, Inc. announced that the U.S....
The global product development team expansion and infrastructure ... co-development and co-commercialization with Ascentage Pharma in China.
To date, Ascentage Pharma has built a commercialization team possessing ... Inc. ("Pfizer) to evaluate the combination of Ascentage Pharma's...
Global Bcl-2-Like Protein 1 Market Growth, Analysis, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.
Global Bcl-2-Like Protein 1 Market Analysis, Size, Share, Demand & Forecast 2019-2026: AbbVie Inc, Ascentage Pharma Group Corp Ltd.
Other Companies in Rockville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $24.7M | 155 | 10% | N/A |
#2 | $7.5M | 157 | 13% | N/A |
#3 | $7.5M | 158 | N/A | N/A |
#4 | $47.5M | 160 | 3% | N/A |
#5 | $17.6M | 160 | 31% | N/A |